Eleusis SPAC
Care Delivery Model Comparison
Reimbursement
Model
Available
Therapies
Patient Acquisition
(Referral Sources)
Oversight and
Safety Monitoring
Andala-Managed Clinics
Expected coverage and reimbursement
by large insurance providers
SPRAVATO (generally covered)
IV/IM Ketamine if ineligible for
SPRAVATO (partial or no coverage)
Direct, PCP, Psychiatrist, Psychotherapist,
Telehealth Platforms
Psychiatric Consultation and Oversight;
FDA REMS Compliance
Ketamine Clinics
(Cash-Pay)
"Out-of-pocket" patient payment
IV/IM/Oral Ketamine
Source: 1) Partheniou, A. (2021) Psychedelics - A possible disrupter to legacy treatments, Stifel Nicholaus Canada Inc, 01/14/2021 (estimate based in part on data from existing ketamine clinics).
Direct
Unknown
27View entire presentation